Диссертация (1144999), страница 54
Текст из файла (страница 54)
44 (Suppl. 1). – P. 1235.153. Efficiency of liver stiffness measurement (Fibroscan) for the follow-up of patientswith primary biliary cirrhosis / M. Gomez-Dominguez, J. Jimenez-Ridruejo, J.Moreno Monteagudo [et al.] // Hepatology. – 2006. – Vol. 44 (Suppl. 1). – P. 1191.154. Elias, H. Тhe liver. Моrphоlоgy, Biochemistry, Physiology / H. Elias - NewYork: V. 1, 1963 – P. 41.155.
Emoto, N. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum / N. Emoto, M. Yanagisawa //J Biol. Chem. – 1995. – Vol. 270. – P. 15262-15268.156. Endoscopic ultrasonographic signs of portal hypertension in cirrhosis / P. Burtin,P. Cales, F. Oberti [et al.] // Gastrointest Endosc 44.
– 1996. – P. 257-261.157. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension / PS. Kamath, GM. Tyce, VM. Miller [et al.] // Hepatology – 1999. –Vol. 30– P. 401-407.158. Endothelin-1 production by hepatic endothelial cells: Characterization and augmentation by endotoxin exposure / AT. Eakes, KM.
Howard, JE. Miller [et al.] // AmJ Physiol. – 1997. – Vol. 272. – P. 605-611.159. ET-1 induced alterations of hepatic microcirculation: Sinusoidal and extrasinusoidal sites of action / М. Bauer, JX. Zhang, I. Bauer [et al.] // Am J Physiol. 267 –1994. – Р. 143-149.160. Evaluation of a panel of non-invasive serum markers to differentiate mild frommoderate to advanced liver fibrosis in chronic hepatitis C patients / K. Patel, S.C.Gordon, I. Jacobson [et al.] // J. Hepatol. – 2004.
– Vol. 41. – P. 935-942.161. Fernandez, M. Splanchnic angiogenesis in portal hypertension / M. Fernandez //EASL monothematic conference: Portal hypertension: Advances in knowledge, evaluation and management. Budapest, Hungary, January 22-24. – 2009. – P. 34.162. Fontana, R.J. Noninvasive monitoring of patient with chronic hepatitis / R.J.
Fontana, S.F.A Fontana Loc // Hepatology. – 2002. – Vol. 36. – P. 57-64.291163. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis / R.G. Knodell, KG. Ishak,W.S. Black [et al.] // Hepatology. – 1981. – P. 431-435.164. Frequency and clinical implications of increased pulmonary artery pressures inliver transplant patients / M.
Castro, MJ. Krowka, DR. Schroeder [et al.] // Mayo ClinProc 71. – 1996. – Р. 543-551.165. Friedman, S. Hepatic fibrogenesis / S. Friedman // EASL monothematic conference: Portal hypertension: advances in knowledge, evaluation and management (Budapest, Hungary, January 22-24, 2009).
– 2009. – P. 36-37.166. Garcia-Tsao, G. Management of varices and variceal hemorrhage in cirrhosis /Garcia-Tsao, G., Bosch J / N. Engl. J. Med. – 2010. – Vol. 362. – P. 823–832.167. Geerts, A. History, heterogeneity, developmentalbiology, and functions of quiescent hepatic stellate cells /А. Geerts //Semin. Liver Dis. – 2001. – Vol. 21. – P.
311335.168. Gregory, DC. Evaluation of skin testing methods employed in the diagnosis ofpenicillin allergy. / DC. Gregory , J. Gregory , L. Tuft // Am J Med Sci. – 1955. Vol. 230, № 6. – Р. 370-379.169. Groszmann, R. J. Hyperkinetic circulation / RJ. Groszmann // EASL monothematicconference: Portal hypertension: Advances in knowledge, evaluation and management Budapest, Hungary, January 22-24. – 2009. – P. 23-24.170. Growth inhibitory properties of endothelin-1 in activated human hepatic stellatecells: A cyclic adenosine monophosphate-mediated pathway.
Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin Breceptors / A. Mallat, AM. Preaux, С. Serradeil-Le Gal [et al.] // J Clin Invest. –1996. – Vol. 98. – P. 2771-2778.171. Gumicio, J. Liver cell heterogeneity / The liver biology and pathology / J. Gumicio, D. Miller. – New York, 1982.
– P. 647-661.172. Haemodynamic effect oftriglycyl-lysine-vasopressin (glypressin) on intravascularesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial / R. Cestari, M. Braga, G. Missale [et al.] // J. Hepatol. 10. – 1990. – P.205.173. Hamilton, C.A. Chemistry, mode of action and еxperimental pharm-acology ofmoxonidine. In: van The putative I1 – imidazoline Receptor Agonist Moxonidine.Under PA. Zwieten edition.
/ C.A Hamilton. - 2nd Edition. – London: Roy Soc Med,1996. – P.7-30.174. Hayes, P. Pharmacological modification of splanchnic blood flow / Р. Hayes //EASL monothematic conference: Portal hypertension: Advances in knowledge, evaluation and management Budapest, Hungary, January 22-24. – 2009. – P. 34.175. Hemodynamic effects of a clonidine-induccd decrease in sympathetic tone in patients with cirrhosis / R. Moreau, S. Lee, A. Hadengue [et al.] // Hepatology.
– 1987.– Vol. 7. - Р. 149.176. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage / RJ. Groszmann, J. Bosch, ND.Grace [et al.] // Gastroenterology. –1990. – Vol. 99. – P. 1401-1407.292177. Hennenberg, М. Sauerbruch T Rho proteins and reglation of vascular tone in cirrhosis / М. Hennenberg, J. Trebicka, J. Heller // EASL monothematic conference:Portal hypertension: Advances in knowledge, evaluation and management Budapest,Hungary, January 22-24.
– 2009. - P. 28-29.178. Hepatic effects of endothelin. Receptor characterization and endothelin-inducedsignal transduction in hepatocytes / CR. Gandhi, RH. Behal, SA. Harvey [et al.] //Biochem J. – 1992. – Vol. 287. – Р. 897-904.179. Hepatic venous pressure gradient predicts clinical decompensation in patientswith compensated cirrhosis / C. Ripoll , R. Groszmann, G.
Garcia-Tsao [et al.]//Gastroenterology. – 2007. - Vol. 133 (Suppl. 2). – P. 481-488.180. Homodynamic and neirohumoral effects of moxonidine in patients with essentialhypertension / V. Mitrovic, W. Patyna, J. Huting [et al.] // Cardiovasc. Drugs Ther. –1991. – Vol. 5. – Р. 967-972.181. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitricoxide levels in hepatic and portal veins / S.
Battisia, F. Bar, G. Mengezzi [et al.] //Hepatology 26. – 1997. – P. 75-80.182. Impaired endothelial nitric oxide synthase activity associated with enhancedcaveolin binding in experimental cirrhosis in the rat / V. Shah, M. Toruner, F. Haddad [et al.] // Gastroenterology. – 1999. – Vol. 117. – P. 1222-1228.183. Influence of metabolic syndrome on liver stiffness in subjects without overt liverdisease / D. Roulot, S. Czernichow, H. Le Clesiau [et al.] // Hepatology. – 2006. –Vol. 44 (Suppl.
1). – P. 812.184. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons / AG. Baynash, К. Hosoda, А.Giaid [et al.]// Cell 79. – 1994. – Р 1277-1285.185. Interobserver and interequipment variability of hepatic, splenic, and renal arterialDoppler resistance indices in normal subjects and patients with cirrhosis / D. Sacerdoti, S. Gaiani, P. Buonamico [et al.] // J Hepatol.
– 1997. – Vol. 27. – P. 986-992.186. Iredale, J. Reversibility of liver fibrosis / J. Iredale // EASL monothematic conference: Portal hypertension: Advances in knowledge, evaluation and management Budapest, Hungary, January 22-24. – 2009. – P. 39.187. Iwakiri, Y. Factors modulating e-NOS expression activity / Y. Iwakiri // EASLmonothematic conference: Portal hypertension: Advances in knowledge, evaluationand management Budapest, Hungary, January 22-24. – 2009. – P.
16-17.188. Jafri, SM. Antiviral therapy for chronic hepatitis B / SM. Jafri, AS. Lok// ClinLiver Dis. -2010. Vol.14. - P. 425-438189. Kawada, N. Eicosanoid-mediated contractility of hepatic stellate cells / N. Kawada, H. Klein, K. Decker// Biochem J. – 1992.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
